JP2008542237A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008542237A5 JP2008542237A5 JP2008512825A JP2008512825A JP2008542237A5 JP 2008542237 A5 JP2008542237 A5 JP 2008542237A5 JP 2008512825 A JP2008512825 A JP 2008512825A JP 2008512825 A JP2008512825 A JP 2008512825A JP 2008542237 A5 JP2008542237 A5 JP 2008542237A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- topiramate
- composition according
- organic solvent
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05104491 | 2005-05-25 | ||
| US69039105P | 2005-06-14 | 2005-06-14 | |
| PCT/EP2006/062518 WO2006125774A1 (en) | 2005-05-25 | 2006-05-23 | Pediatric formulation of topiramate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008542237A JP2008542237A (ja) | 2008-11-27 |
| JP2008542237A5 true JP2008542237A5 (enExample) | 2009-07-09 |
Family
ID=35045349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008512825A Withdrawn JP2008542237A (ja) | 2005-05-25 | 2006-05-23 | トピラメートの小児科用製剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060270611A1 (enExample) |
| EP (1) | EP1888030A1 (enExample) |
| JP (1) | JP2008542237A (enExample) |
| CN (1) | CN101257889A (enExample) |
| AR (1) | AR053737A1 (enExample) |
| AU (1) | AU2006251213A1 (enExample) |
| BR (1) | BRPI0610210A2 (enExample) |
| CA (1) | CA2609719A1 (enExample) |
| MX (1) | MX2007014713A (enExample) |
| RU (1) | RU2007148444A (enExample) |
| TW (1) | TW200716202A (enExample) |
| WO (1) | WO2006125774A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2246044A1 (en) * | 2009-04-21 | 2010-11-03 | Pierre Fabre Dermo-Cosmétique | Paediatric solutions comprising a beta-blocker |
| WO2011141490A1 (en) | 2010-05-10 | 2011-11-17 | Euro-Celtique S.A. | Combination of active loaded granules with additional actives |
| NZ603173A (en) | 2010-05-10 | 2014-10-31 | Euro Celtique Sa | Manufacturing of active-free granules and tablets comprising the same |
| CA2795324C (en) * | 2012-11-09 | 2015-07-14 | Purdue Pharma | Pharmaceutical compositions comprising hydromorphone and naloxone |
| US9549909B2 (en) | 2013-05-03 | 2017-01-24 | The Katholieke Universiteit Leuven | Method for the treatment of dravet syndrome |
| EP3068397A1 (en) | 2013-11-13 | 2016-09-21 | Euro-Celtique S.A. | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome |
| CN104188920A (zh) * | 2014-07-28 | 2014-12-10 | 安徽省逸欣铭医药科技有限公司 | 托吡酯颗粒剂及其制备方法 |
| RU2740919C2 (ru) * | 2015-08-24 | 2021-01-21 | Зодженикс Интернэшнл Лимитед | Способы лечения синдрома леннокса-гасто с использованием фенфлурамина |
| WO2017085687A1 (en) | 2015-11-20 | 2017-05-26 | West-Ward Pharmaceuticals International Limited | Stable formulation of phenobarbital sodium injection |
| JP2019507111A (ja) | 2015-12-22 | 2019-03-14 | ゾゲニクス インターナショナル リミテッド | 代謝抵抗性フェンフルラミン類縁体およびその使用法 |
| EP3800177B1 (en) | 2015-12-22 | 2025-01-29 | Zogenix International Limited | Fenfluramine compositions and methods of preparing the same |
| RU2021106383A (ru) | 2016-08-24 | 2021-04-05 | Зодженикс Интернэшнл Лимитед | Состав для ингибирования образования агонистов 5-ht2b и способы его применения |
| US10682317B2 (en) | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
| WO2019186515A1 (en) * | 2018-03-30 | 2019-10-03 | Ftf Pharma Private Limited | Liquid pharmaceutical compositions of antiepileptic drugs |
| WO2019216919A1 (en) | 2018-05-11 | 2019-11-14 | Zogenix International Limited | Compositions and methods for treating seizure-induced sudden death |
| EP3806835A1 (en) | 2018-06-14 | 2021-04-21 | Zogenix International Limited | Compositions and methods for treating respiratory depression with fenfluramine |
| GB2596184A (en) * | 2018-09-13 | 2021-12-22 | Ftf Pharma Private Ltd | Non-aqueous solutions for oral dosage |
| EA202191079A1 (ru) | 2018-11-19 | 2021-09-20 | Зодженикс Интернэшнл Лимитед | Способы лечения синдрома ретта с применением фенфлурамина |
| WO2020104837A1 (en) | 2018-11-21 | 2020-05-28 | Rosemont Pharmaceuticals Limited | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability |
| US20210169844A1 (en) | 2019-12-10 | 2021-06-10 | Tulex Pharmaceuticals Inc. | Compositions and methods for treating epilepsy, seizures and other conditions |
| GB2594242A (en) * | 2020-04-14 | 2021-10-27 | Syri Ltd | A stable and ready to administer liquid pharmaceutical composition of topiramate |
| US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| CN117159458A (zh) * | 2022-05-27 | 2023-12-05 | 北京万全德众医药生物技术有限公司 | 托吡酯口服溶液及其制备方法 |
| US12109188B1 (en) * | 2023-03-24 | 2024-10-08 | Tap Pharmaceuticals Ag | Liquid pharmaceutical formulations of topiramate |
| US12290504B2 (en) | 2023-04-11 | 2025-05-06 | Tap Pharmaceuticals Ag | Aqueous formulations of topiramate |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| IL103172A (en) * | 1991-09-19 | 1997-01-10 | Mcneilab Inc | Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol |
| US20030077227A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| JP2004331502A (ja) * | 2001-06-18 | 2004-11-25 | Ortho Mcneil Pharmaceut Inc | 視神経細胞保護剤 |
| US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
| JP2007511519A (ja) * | 2003-11-14 | 2007-05-10 | アルザ・コーポレーシヨン | 液状投薬形態物におけるトピラメートの制御放出 |
-
2006
- 2006-05-23 AU AU2006251213A patent/AU2006251213A1/en not_active Abandoned
- 2006-05-23 RU RU2007148444/15A patent/RU2007148444A/ru not_active Application Discontinuation
- 2006-05-23 MX MX2007014713A patent/MX2007014713A/es not_active Application Discontinuation
- 2006-05-23 CA CA002609719A patent/CA2609719A1/en not_active Abandoned
- 2006-05-23 JP JP2008512825A patent/JP2008542237A/ja not_active Withdrawn
- 2006-05-23 BR BRPI0610210-7A patent/BRPI0610210A2/pt not_active IP Right Cessation
- 2006-05-23 WO PCT/EP2006/062518 patent/WO2006125774A1/en not_active Ceased
- 2006-05-23 US US11/419,834 patent/US20060270611A1/en not_active Abandoned
- 2006-05-23 EP EP06755288A patent/EP1888030A1/en not_active Withdrawn
- 2006-05-23 CN CNA2006800178845A patent/CN101257889A/zh active Pending
- 2006-05-24 AR ARP060102160A patent/AR053737A1/es not_active Application Discontinuation
- 2006-05-24 TW TW095118344A patent/TW200716202A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU720132B2 (en) | Pharmaceutical compositions | |
| CA2359813A1 (en) | Nicotine mucosal spray | |
| WO2007070504A3 (en) | Stable and palatable oral liquid sumatriptan compositions | |
| JP2010525059A5 (enExample) | ||
| EA201171429A1 (ru) | Противораковое соединение и содержащая его фармацевтическая композиция | |
| WO2005117911A3 (en) | Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin | |
| JP2010513487A5 (enExample) | ||
| RU2007148444A (ru) | Педиатрическая композиция топирамата | |
| JP2015527385A5 (enExample) | ||
| WO2008143240A1 (ja) | 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法 | |
| RU2488393C2 (ru) | Жидкие композиции, включающие валсартан | |
| JP2014530801A5 (enExample) | ||
| RU2015102575A (ru) | Жидкие композиции рацекадотрила | |
| JP2013500322A5 (enExample) | ||
| WO2002009731A1 (fr) | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches | |
| RU2014101990A (ru) | Жидкая фармацевтическая композиция, включающая нитизинон | |
| RU2008118150A (ru) | Снижение солености с помощью подсластителей | |
| RU2015134148A (ru) | Галеновая форма для введения активного действующего вещества | |
| JP2021513521A5 (enExample) | ||
| JP2015536995A5 (enExample) | ||
| JP2022527630A5 (enExample) | ||
| WO2007073226A1 (en) | Method for treating a mammal by administration of a compound having the ability to release co | |
| TW200911302A (en) | Pharmaceutical solutions | |
| JP2005535644A5 (enExample) | ||
| CN103458874A (zh) | 对组合物的改进和与组合物有关的改进 |